ZEKE CAPITAL ADVISORS, LLC – Eli Lilly and Company Transaction History
ZEKE CAPITAL ADVISORS, LLC portfolio value:
$1.31M
portfolio value
ZEKE CAPITAL ADVISORS, LLC quarter portfolio value change:
-0.27%
quarter
Eli Lilly and Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.02% | 1 shares | -3K | $323.35 | 4.06K |
| Q2 2022 | share | Increase | +4.21% | 164 shares | 201K | $324.23 | 4.06K |
| Q1 2022 | share | Increase | 0.00% | 3.89K shares | 1.11M | $286.37 | 3.89K |
| Q2 2020 | share | Decrease | -100.00% | -1.65K shares | -229K | $160.1 | 0 |
| Q1 2020 | share | Decrease | -86.90% | -10.96K shares | -1.43M | $134.64 | 1.65K |
| Q4 2019 | share | Decrease | -4.99% | -663 shares | 173K | $126.91 | 12.62K |
| Q3 2019 | share | Increase | +1.98% | 258 shares | 43K | $107.36 | 13.28K |
| Q2 2019 | share | Decrease | -19.08% | -3.07K shares | -646K | $105.74 | 13.02K |
| Q1 2019 | share | Decrease | -39.33% | -10.43K shares | -982K | $123.17 | 16.09K |
| Q4 2018 | share | Decrease | -34.83% | -14.18K shares | -1.29M | $109.26 | 26.53K |
| Q3 2018 | share | Increase | +0.74% | 300 shares | 921K | $100.8 | 40.71K |
| Q2 2018 | share | Increase | +46.63% | 12.85K shares | 1.31M | $79.72 | 40.41K |
| Q1 2018 | share | Increase | +7.42% | 1.90K shares | -34K | $71.78 | 27.56K |
| Q4 2017 | share | Increase | +7.61% | 1.81K shares | 127K | $77.79 | 25.66K |
| Q3 2017 | share | Increase | +158.80% | 14.63K shares | 1.28M | $78.29 | 23.84K |
| Q2 2017 | share | Increase | +24.75% | 1.82K shares | 137K | $74.85 | 9.21K |
| Q1 2017 | share | Increase | +50.18% | 2.46K shares | 259K | $76 | 7.38K |
| Q4 2016 | share | Increase | 0.00% | 4.91K shares | 362K | $66.02 | 4.91K |